Siste måned
30 dager
+99 623
NETTO POSISJON (NOK)
Handler
2
Kjøp
99 623
Salg
0
6 måneder
180 dager
+99 623
NETTO POSISJON (NOK)
Handler
5
Kjøp
99 623
Salg
0
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 03.09.2026 |
Timothy Herpin
Chief Business Officer
|
384 500 | - | - |
| 02.09.2026 |
Eric Falcand
Chair of the Board of Directors
|
12 000 | 8.30 | 99 623 |
| 23.07.2026 |
Karim Benhadji
Chief Medical Officer
|
384 500 | - | - |
| 23.07.2026 |
Renée Amundsen
Chief Operating Officer
|
769 000 | - | - |
| 09.04.2026 |
Darlene Deptula-Hicks
Board member
|
100 000 | - | - |
| 09.01.2026 |
Brynjar Forbergskog
Board Member
via Saturn Invest AS
|
2 222 222 | 9.00 | 19 999 998 |
| 11.12.2025 |
Øystein Rekdal
Chief Executive Officer
|
10 000 | 10.00 | 99 984 |
Pressemeldinger
| Dato | Melding |
|---|---|
| 03.09.2026 |
Lytix Biopharma ASA: Grant of share options to management and key personnel
Oslo, Norway – 3 September 2026 – Lytix Biopharma ASA (the “Company”) announces that the Board of Directors has approved the grant of 1,076,600 share ...
|
| 02.09.2026 |
Lytix Biopharma ASA: Mandatory notification of trade by primary insider
Oslo, 2 September 2026 – Eric Falcand, Chair of the Board of Directors and primary insider in Lytix Biopharma ASA, has today purchased 12,000 shares i...
|
| 23.07.2026 |
Lytix Biopharma ASA: Grant of share options to management and key personnel
Oslo, Norway – 23 July 2026 – Lytix Biopharma ASA (the “Company”) announces that the Board of Directors has approved the grant of 1,230,400 share opti...
|
| 09.04.2026 |
Lytix Biopharma AS: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER - GRANT OF SHARE OPTIONS
Oslo, 9 April 2026: Lytix Biopharma AS (the “Company”) has granted 100,000 share options to primary insider Darlene Deptula-Hicks, a member of the Com...
|
| 09.01.2026 |
Lytix Biopharma AS – Mandatory notification of trade by close associate of primary insider
Oslo, Norway, 9 January 2026: Reference is made to the stock exchange announcement published by Lytix Biopharma AS ("Lytix" or the "Company") earlier ...
|
| 11.12.2025 |
LYTIX BIOPHARMA AS – MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
Oslo, Norway, 11 December 2025: Primary insider Øystein Rekdal, Chief Executive Officer of Lytix Biopharma AS, has today acquired 10,000 shares in Lyt...
|
| Vis færre ▲ | |
Vis alle 6 meldinger
▼